ObsEva SA (OBSN.SW)
- Previous Close
0.0060 - Open
0.0066 - Bid --
- Ask --
- Day's Range
0.0054 - 0.0090 - 52 Week Range
0.0040 - 0.0896 - Volume
882,377 - Avg. Volume
533,754 - Market Cap (intraday)
1.031M - Beta (5Y Monthly) 0.66
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2900 - Earnings Date May 13, 2024 - May 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women's reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.
www.obseva.comRelated News
Performance Overview: OBSN.SW
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OBSN.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OBSN.SW
Valuation Measures
Market Cap
1.03M
Enterprise Value
-3.89M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.04
Price/Book (mrq)
0.09
Enterprise Value/Revenue
-0.20
Enterprise Value/EBITDA
0.19
Financial Highlights
Profitability and Income Statement
Profit Margin
40.34%
Return on Assets (ttm)
10.05%
Return on Equity (ttm)
1,576.52%
Revenue (ttm)
19.64M
Net Income Avi to Common (ttm)
7.92M
Diluted EPS (ttm)
-0.2900
Balance Sheet and Cash Flow
Total Cash (mrq)
3.34M
Total Debt/Equity (mrq)
24.32%
Levered Free Cash Flow (ttm)
20.15M
Company Insights: OBSN.SW
OBSN.SW does not have Company Insights